Inhibition of the reward system by antipsychotic treatment

21Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The mesolimbic dopaminergic reward system is responsible for the negative affective symptomatology of schizophrenia, which may be related to a low dopamine tonus within the ventral striatum. The monetary incentive delay (MID) task can be used to study the response of the ventral striatum to incentive stimuli. We show that activation of the ventral striatum is low in patients with schizophrenia, and that this low activation is related to primary and secondary negative symptoms induced by neuroleptics, also known as antipsychotics. Switching from first-(typical) to second-generation (atypical) antipsychotics increased activation of the ventral striatum due to less blocking of dopamine D2 receptors. This and similar studies show that functional magnetic resonance imaging (fMRI) tasks are suitable to investigate important aspects of antipsychotic mechanisms.

Cite

CITATION STYLE

APA

Juckel, G. (2016). Inhibition of the reward system by antipsychotic treatment. Dialogues in Clinical Neuroscience, 18(1), 109–114. https://doi.org/10.31887/dcns.2016.18.1/gjuckel

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free